Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Factorial Design02:01

Factorial Design

Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracting host-specific developmental signatures from longitudinal microbiome data.

PLoS computational biology·2026
Same author

Analysis of microbiome high-dimensional experimental design data using generalized linear models and ANOVA simultaneous component analysis.

Frontiers in microbiomes·2026
Same author

ACMTF-R: Supervised multi-omics data integration uncovering shared and distinct outcome-associated variation.

PloS one·2026
Same author

Predictive mechanistic modelling of vegetable oil autoxidation using a parametrised kinetic network.

Current research in food science·2025
Same author

Mechanistic kinetic model to elucidate lipid oxidation mechanisms in spray-dried microencapsulated oils.

Food chemistry·2025
Same author

Improved epigenetic age prediction models by combining sex chromosome and autosomal markers.

Epigenetics & chromatin·2025

Related Experiment Videos

Multilevel data analysis of a crossover designed human nutritional intervention study.

Ewoud J J van Velzen1, Johan A Westerhuis, John P M van Duynhoven

  • 1Biosystems Data Analysis, Swammerdam Institute for Life Sciences, Universiteit van Amsterdam, Nieuwe Achtergracht 166, 1018 WV Amsterdam, The Netherlands.

Journal of Proteome Research
|August 30, 2008
PubMed
Summary
This summary is machine-generated.

A novel multilevel method enhances

Related Experiment Videos

Area of Science:

  • Metabolomics
  • Statistical Analysis
  • Bioinformatics

Background:

  • Crossover studies are common in nutritional and drug intervention research.
  • Analyzing 'omics' data from these studies presents challenges due to within- and between-subject variability.
  • Existing methods may not fully leverage the crossover design for robust analysis.

Purpose of the Study:

  • To introduce a new statistical method for analyzing 'omics' data from crossover intervention studies.
  • To effectively separate and analyze between- and within-subject variations.
  • To improve the detection of treatment effects in complex biological data.

Main Methods:

  • A multivariate statistical approach extending the paired t test.
  • Generation of separate submodels for between- and within-subject variation.
  • Application of multilevel Principal Component Analysis (PCA) and Partial Least Squares-Discriminant Analysis (PLS-DA).
  • Validation using cross-model validation and permutation testing.
  • Identification of key metabolites using rank products.

Main Results:

  • The multilevel approach successfully splits and analyzes variations.
  • Multilevel PCA effectively distinguished between subjects.
  • Multilevel PLS-DA revealed a significant net treatment effect (p << 0.0002).
  • This represents a substantial improvement over standard PLS-DA (p = 0.058).
  • NMR signals contributing to the classification were identified.

Conclusions:

  • The proposed multilevel method is a powerful tool for analyzing 'omics' data from crossover studies.
  • It significantly enhances the statistical power to detect treatment effects compared to conventional methods.
  • This approach offers a robust framework for understanding metabolic responses to interventions.